242 related articles for article (PubMed ID: 10823367)
21. Medicare beneficiary out-of-pocket costs: are Medicare Advantage Plans a better deal?
Biles B; Hersch Nicholas L; Guterman Stuart S
Issue Brief (Commonw Fund); 2006 May; 19():1-16. PubMed ID: 16733884
[TBL] [Abstract][Full Text] [Related]
22. Medicare risk programs and pharmacy benefits managers.
Herzfeld J
Med Interface; 1996 Dec; 9(12):75-8. PubMed ID: 10172875
[TBL] [Abstract][Full Text] [Related]
23. Medicare program; catastrophic outpatient drug benefit--HCFA. Proposed rule.
Fed Regist; 1989 Sep; 54(172):37190-208. PubMed ID: 10303826
[TBL] [Abstract][Full Text] [Related]
24. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Interim final rule with comment period.
Office of Inspector General (OIG), HHS
Fed Regist; 2004 May; 69(97):28842-6. PubMed ID: 15151115
[TBL] [Abstract][Full Text] [Related]
25. The last prescription drug benefit: the Medicare Catastrophic Coverage Act of 1988.
Pentecost MJ
J Am Coll Radiol; 2006 Apr; 3(4):240-2. PubMed ID: 17412053
[No Abstract] [Full Text] [Related]
26. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
27. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
Dale SB; Verdier JM
Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
[No Abstract] [Full Text] [Related]
28. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
Cubanski J; Neuman P
Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
[TBL] [Abstract][Full Text] [Related]
29. PBMs and a Medicare prescription drug benefit.
Cohen JP
Food Drug Law J; 2000; 55(3):311-20. PubMed ID: 11824463
[No Abstract] [Full Text] [Related]
30. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
31. Improving the design of competitive bidding in Medicare Advantage.
Cawley JH; Whitford AB
J Health Polit Policy Law; 2007 Apr; 32(2):317-47. PubMed ID: 17463410
[TBL] [Abstract][Full Text] [Related]
32. What will the new medicare drug benefit mean for Minnesota physicians?
Liebow M
Minn Med; 2005 Mar; 88(3):38-41. PubMed ID: 15852596
[TBL] [Abstract][Full Text] [Related]
33. Medicare's outpatient prescription drug benefit.
Dillingham GL; Solomon JH
Pride Inst J Long Term Home Health Care; 1989; 8(1):3-14. PubMed ID: 10303361
[No Abstract] [Full Text] [Related]
34. Assessing Medicare prescription drug plans in four states: balancing cost and access.
Heaton E; Carino T; Dix H
Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
[TBL] [Abstract][Full Text] [Related]
35. Lessons for Medicare Part D in the hemodialysis community.
Nayeem AI; Chertow GM
BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
[TBL] [Abstract][Full Text] [Related]
36. The role of PBMs in implementing the Medicare prescription drug benefit.
Atlas RF
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-504-15. PubMed ID: 15513957
[TBL] [Abstract][Full Text] [Related]
37. Molecular medicine, the Medicare drug benefit, and the need for cost control.
Gillick MR
J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
[TBL] [Abstract][Full Text] [Related]
38. What a Food and Drug lawyer should know about the Medicare Modernization Act.
Azar AM
Food Drug Law J; 2004; 59(2):217-22. PubMed ID: 15318393
[No Abstract] [Full Text] [Related]
39. Prescription drug coverage for people with Medicare.
Stein N
Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
[TBL] [Abstract][Full Text] [Related]
40. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
Fischer MA; Avorn J
Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
